Forum: Néovacs » Forum Néovacs geopend | Eurobench.com

Forum Néovacs geopend

4 Posts
Aantal posts per pagina:  20 50 100 | Omlaag ↓
IEX - Forummoderator
0
Neovacs is a French biotech company focused on the development of Kinoids®, therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.

Groet Henk
Dr. Bob
0

Neovacs is een Frans Biotechbedrijf dat zich richt op de ontwikkeling van Kinoïden, waarmee het zich onderscheidt zich van de passieve immunotherapie met monoklonale antilichamen door in te zetten op een actieve immunotherapie met polyklonale antilichamen (onderstaand de link naar de bedrijfspresentatie op de website).

neovacs.fr/wp-content/uploads/2016/11...
Dr. Bob
0
NEOVACS TO PRESENT FULL RESULTS FROM THE PHASE IIb IFNalpha KINOID CLINICAL STUDY AT THE 13TH INTERNATIONAL LUPUS CONGRESS (LUPUS 2019)
5 - 9 APRIL, SAN FRANCISCO



Paris & Boston, January 24th, 2019 – 17:45 pm CET - Neovacs (Euronext Growth Paris: ALNEV), leader in active immunotherapy for the treatment of auto-immune and inflammatory diseases announces that it has been selected to present the results of its Phase IIb IFNa Kinoid clinical study at the “13th International Lupus Congress (LUPUS 2019)”, to be held from 5th to 9th April in San Francisco.

Professor Frederic Houssiau, “Chairman of the study”, will present the full results which demonstrated:

  • An immune response achieved with 91% of patients treated with IFNa Kinoid together with statistically significant efficacy in reduction of interferon signature
    A statistically significant clinical efficacy on the LLDAS score
    The favorable safety profile of the treatment

Based on these results, Neovacs has launched the preparation of the Phase III clinical development program.


finance.yahoo.com/news/neovacs-presen...
De Troon Jan
0
4 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Plaats een reactie

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd 15-feb-19 17:35
Koers 0,243
Verschil -0,013 (-5,09%)
Hoog 0,259
Laag 0,239
Volume 2.968.859
Volume gemiddeld 0
Volume gisteren 5.171.639